the study on magnetic resonance elastography predicting the cirrhosis and its complication

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035780

Enrollment

Unknown

Registered

2020-08-16

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis

Interventions

entecavir(non-cirrhosis):entecavi

tenofovir(non-cirrhosis):tenofovir

entecavir(cirrhosis):entecavir

tenofovir(cirrhosis) :tenofovir

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged 18-65 years; 2. HBsAg and/or HBVDNA positive exceed 6 months; 3. matched with the critia of the CHB prevention and treatment guideline; 4. signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. HCC or AFP>100ng/ml; 2. pregrant or breasting women; 3. co-infection HAV HCV,HDV,HEV,HIV and with other chronic hepatitis; 4. with contraindication of MRI,gastroscope, liver biopsy; 5. Poor compliance.

Design outcomes

Primary

Measure	Time frame
liver stiffness;incidition of compication;	—

Countries

China

Contacts

Public ContactChen Liang

Shanghai Public Health Clinical Center

chenliang@shphc.org.cn+86 18930810000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026